Research analysts at Brookline Capital Management issued their Q2 2025 earnings estimates for shares of CervoMed in a note issued to investors on Tuesday, March 11th. Brookline Capital Management ...
Brookline Capital Management issued their FY2024 EPS estimates for Perspective Therapeutics in a report released on Monday, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback